Keith A.A. Fox
University of Arizona
2 papers in the Anchorcite directory, published between 2011 and 2018, cited 15,627 times in total.
ORCID profileResearch topics
- Acute Ischemic Stroke Management · 1 paper
- Atrial Fibrillation Management and Outcomes · 1 paper
- Venous Thromboembolism Diagnosis and Management · 1 paper
- Acute Myocardial Infarction Research · 1 paper
- Cardiac Imaging and Diagnostics · 1 paper
- Cardiac Ischemia and Reperfusion · 1 paper
Frequent co-authors
- Kenneth W. Mahaffey · 2 papers
- Manesh R. Patel · 1 paper
- Jyotsna Garg · 1 paper
- Guohua Pan · 1 paper
- Daniel E. Singer · 1 paper
- Werner Hacke · 1 paper
- GÜNTER E. BREITHARDT · 1 paper
- Jonathan L. Halperin · 1 paper
Papers
- Rivaroxaban versus Warfarin in Nonvalvular Atrial FibrillationNew England Journal of Medicine · 2011 · 9,529 citations
BACKGROUND: The use of warfarin reduces the rate of ischemic stroke in patients with atrial fibrillation but requires frequent monitoring and dose adjustment. Rivaroxaban, an oral factor Xa inhibitor, may provide more consistent and predictable anticoagulation than warfarin. METHODS: In…
- Fourth universal definition of myocardial infarction (2018)European Heart Journal · 2018 · 6,098 citations
... ... ... ... In the late 19th century, post-mortem examinations demonstrated a possible relationship between thrombotic occlusion of a coronary artery and myocardial infarction (MI).1 However, it was not until the beginning of the 20th century that the first…
Metadata from OpenAlex (CC0).